Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Datasets
Press/Media
Activities
Fellowships, Honors, and Prizes
Impacts
Search by expertise, name or affiliation
Restricting ciprofloxacin-induced resistant variant formation in biofilm of Klebsiella pneumoniae B5055 by complementary bacteriophage treatment
Vivek Verma
, Kusum Harjai
, Sanjay Chhibber
Research output
:
Contribution to journal
›
Article
›
peer-review
104
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Restricting ciprofloxacin-induced resistant variant formation in biofilm of Klebsiella pneumoniae B5055 by complementary bacteriophage treatment'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Biofilm
100%
Bacteriophage Therapy
100%
Ciprofloxacin
100%
Resistant Variants
100%
Klebsiella Pneumoniae B5055
100%
Bacteriophage
50%
Klebsiella Pneumoniae (K. pneumoniae)
33%
Combination Treatment
33%
Lytic Bacteriophage
33%
Therapeutic Agents
16%
In Vivo Efficacy
16%
Bacterial Isolates
16%
Effective Strategies
16%
No Significant Difference
16%
Increased Vulnerability
16%
Outer Membrane Protein
16%
Pathogenic Potential
16%
Virulence Potential
16%
Individual Treatment
16%
Capsular Polysaccharide
16%
Cell-Associated
16%
Peritoneal Macrophages
16%
Altered Morphology
16%
Immunology and Microbiology
Biofilm
100%
Bacteriophage
100%
Klebsiella pneumoniae
100%
Pathogenic Potential
16%
Outer Membrane
16%
Peritoneal Macrophage
16%
Susceptibility
16%
In Vitro
16%